AbbVie Inc. (ABBV) Free cash flow 2016–2025
AbbVie Inc. (ABBV) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$17.8BFY2025 · since FY2016: $6.6B → $17.8B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $17.8B | -0.1% |
| FY2024 | $17.8B | -19.2% |
| FY2023 | $22.1B | -9.0% |
| FY2022 | $24.2B | +10.3% |
| FY2021 | $22.0B | +31.0% |
| FY2020 | $16.8B | +31.5% |
| FY2019 | $12.8B | -0.1% |
| FY2018 | $12.8B | +35.6% |
| FY2017 | $9.4B | +43.7% |
| FY2016 | $6.6B | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ABBV financial trends
ABBV RevenueABBV Net incomeABBV Net marginABBV Gross profitABBV Gross marginABBV Operating incomeABBV Operating marginABBV Operating cash flowABBV Capital expendituresABBV Return on equityABBV Stock buybacksABBV Dividends paidABBV Total assetsABBV Total liabilitiesABBV Shareholders’ equityABBV overview →